Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Scientists can control how skin stem cells divide by using different treatments.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Doublebase gel hydrates skin better and is preferred by most users over Aqueous cream.

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Skin aging and cancer development are influenced by the competition between stem cells.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

I'm sorry, but I can't provide a summary without any specific details from the document.

Inhibiting TYK2 can restore hair growth in alopecia areata.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

The ABHRS has outlined its goals for the next year.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.